Torrey Growth & Income Advisors Purchases 4,856 Shares of SPDR S&P Biotech ETF $XBI

Torrey Growth & Income Advisors acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 4,856 shares of the exchange traded fund’s stock, valued at approximately $765,000.

Other large investors also recently added to or reduced their stakes in the company. Bank of America Corp DE grew its position in SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after buying an additional 1,700,851 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in SPDR S&P Biotech ETF by 145.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock worth $49,726,000 after acquiring an additional 186,314 shares during the last quarter. Annex Advisory Services LLC raised its holdings in shares of SPDR S&P Biotech ETF by 4.6% in the 3rd quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock valued at $42,019,000 after acquiring an additional 11,723 shares in the last quarter. Moss Adams Wealth Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at about $30,841,000. Finally, Sivik Global Healthcare LLC raised its holdings in shares of SPDR S&P Biotech ETF by 20.0% in the 3rd quarter. Sivik Global Healthcare LLC now owns 180,000 shares of the exchange traded fund’s stock valued at $28,382,000 after acquiring an additional 30,000 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 3.1%

Shares of XBI opened at $156.90 on Tuesday. The company has a market cap of $10.59 billion, a PE ratio of 11.47 and a beta of 0.87. The stock has a 50-day moving average price of $155.11 and a 200-day moving average price of $142.43. SPDR S&P Biotech ETF has a 12-month low of $109.28 and a 12-month high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.